Last Posted: May 08, 2020
- Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions
P Deverka et al, Value in Health, May 2020 - Complex patterns of inheritance, including synergistic heterozygosity, in inborn errors of metabolism: Implications for precision medicine driven diagnosis and treatment.
Vockley Jerry et al. Molecular genetics and metabolism 128(1-2) 1-9 - High-throughput sequencing in clinical oncology: from past to present.
Mery Benoîte et al. Swiss medical weekly 2019 Mar 149w20057 - Resolving complexity in mitochondrial disease: Towards precision medicine.
Boggan Róisín M et al. Molecular genetics and metabolism 128(1-2) 19-29 - Barriers and facilitators to dissemination and adoption of precision medicine among Hispanics/Latinos.
Canedo Juan R et al. BMC public health 2020 May 20(1) 603 - Precision medicine in distinct heart failure phenotypes: Focus on clinical epigenetics.
Napoli Claudio et al. American heart journal 2020 Mar 224113-128 - Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib.
Tardif Jean-Claude et al. American heart journal 2020 222157-165 - Translating insights from neuropsychiatric genetics and genomics for precision psychiatry.
Rees Elliott et al. Genome medicine 2020 Apr 12(1) 43 - Returning genomic results in a Federally Qualified Health Center: the intersection of precision medicine and social determinants of health
GQ Shaibi et al, Genetics in Medicine, May 6, 2020 - Genes and genomes and unnecessary complexity in precision medicine
RS Sing et al, NPJ Digital Medicine, May 4, 2020
No hay comentarios:
Publicar un comentario